Biomarkers, menopausal hormone therapy and risk of venous thrombosis: The Women's Health Initiative

Essentials Venous thrombosis is the most common vascular complication of menopausal hormone use. We studied biomarkers to predict thrombosis with hormones in the Women's Health Initiative. Lower proteins C and S, and higher D‐dimer were related to thrombosis risk. The 25% of women with high D‐d...

Descripción completa

Detalles Bibliográficos
Autores principales: Cushman, Mary, Larson, Joseph C., Rosendaal, Frits R., Heckbert, Susan R., Curb, J. David, Phillips, Lawrence S., Baird, Alison E., Eaton, Charles B., Stafford, Randall S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles: Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974918/
https://www.ncbi.nlm.nih.gov/pubmed/30046733
http://dx.doi.org/10.1002/rth2.12100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974918/
https://www.ncbi.nlm.nih.gov/pubmed/30046733
http://dx.doi.org/10.1002/rth2.12100

Ejemplares similares